Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes
Launched by MIKE O'CALLAGHAN MILITARY HOSPITAL · Oct 22, 2014
Trial Information
Current as of May 10, 2025
Completed
Keywords
ClinConnect Summary
This is a prospective cohort research study conducted in the Mike O'Callaghan Federal Medical Center (MOFMC), Department of Family Medicine Residency and Obstetrics Clinics. Subjects will be pregnant female active duty or DoD beneficiaries 18 years or older recruited from the MOFMC, Department of Family Medicine Residency Clinic, and Obstetrics Orientation Class at Nellis AFB. At the screening, the Research Assistant discusses the study, answers all questions, obtains Informed Consent, and schedules appointments for routine OB care. The research design includes a screening visit to obtain w...
Gender
FEMALE
Eligibility criteria
- • THIS STUDY IS BEING CONDUCTED AT A MILITARY INSTALLATION. YOU MUST HAVE MILITARY INSURANCE IN ORDER TO PARTICIPATE IN THIS STUDY.
- Inclusion:
- • Active duty or DoD beneficiaries of childbearing age 18 years or older with a positive pregnancy test (beta human chorionic gonadotropin).
- Exclusion:
- * Active duty or DoD beneficiaries of childbearing age 18 years or older with a positive pregnancy test (beta human chorionic gonadotropin) known to have and/or develop during the study any of the following upon review of their medical record:
- • Hemoglobinopathy (including sickle cell disease or trait, thalassemia)
- • Chronic kidney disease
- • Diabetes
- * Active duty or DoD beneficiaries of childbearing age 18 years or older with a positive pregnancy test (beta human chorionic gonadotropin) taking any of the following:
- • Erythropoietin
- • Daily oral steroids
About Mike O'callaghan Military Hospital
Mike O’Callaghan Military Hospital is a premier healthcare facility dedicated to providing comprehensive medical services to military personnel and their families. As a clinical trial sponsor, the hospital is committed to advancing medical research and enhancing treatment options through rigorous clinical studies. With a focus on innovative therapies and patient-centered care, the hospital collaborates with leading researchers to ensure high standards of safety and efficacy in its trials. The institution plays a vital role in contributing to the broader medical community while maintaining a steadfast commitment to the health and well-being of those who serve.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nellis Air Force Base, Nevada, United States
Patients applied
Trial Officials
Paul Crawford, MD
Principal Investigator
Mike O'Callaghan Federal Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials